BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  AbbVie Announces Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection

  May 24, 2026

   · 

  10 min read
• Press Releases

  ClearNote Health to Present Early Detection Validation Data for Avantect® Pancreatic Cancer Test at 2026 ASCO Annual Meeting

  May 24, 2026

   · 

  4 min read
• Press Releases

  Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors

  May 24, 2026

   · 

  13 min read
• Press Releases

  Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings

  May 24, 2026

   · 

  1 min read
• Press Releases

  FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting

  May 24, 2026

   · 

  5 min read
• Press Releases

  20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand

  May 24, 2026

   · 

  4 min read
• Press Releases

  Caris Life Sciences to Present 32 Studies at ASCO 2026 Highlighting Advances in Multi-omic Biomarker Research and Real-World Evidence

  May 24, 2026

   · 

  14 min read
• Press Releases

  Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - May 22, 2026

  May 24, 2026

   · 

  2 min read
• Press Releases

  Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia

  May 24, 2026

   · 

  15 min read
• Press Releases

  Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class

  May 24, 2026

   · 

  5 min read